Hematological abnormalities in HIV-infected patients

International Journal of Infectious Diseases

Volumn 15, Issue 12, 2011, Pages

  De Santis, Gil Cunha ^a   Brunetta, Denise Menezes ^a   Vilar, Fernando Crivelenti ^a   Brandão, Renata Amorim ^a   de Albernaz Muniz, Renata Zomer ^a   de Lima, Geovana Momo Nogueira ^a   Amorelli Chacel, Manuela Emiliana ^a   Covas, Dimas Tadeu ^a   Machado, Alcyone Artioli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anemia; CD4 count; Mortality; Neutropenia; Thrombocytopenia; Viral load

Indexed keywords

CD4 ANTIGEN; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CYTOPENIA; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NEUTROPENIA; NEUTROPHIL; THROMBOCYTOPENIA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTI-HIV AGENTS; BLOOD CELL COUNT; BRAZIL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HEMATOLOGIC DISEASES; HEMOGLOBINS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; RNA, VIRAL; THROMBOCYTOPENIA; VIRAL LOAD; YOUNG ADULT; ZIDOVUDINE;

EID: 82455212840     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.08.001     Document Type: Article

References (27)

1. Anastos K., Kalish L.A., Hessol N., Weiser B., Melnick S., Burns D., et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS 1999, 13:1717-1726.
2. Kim S., Hughes M.D., Hammer S.M., Jackson J.B., DeGruttola V., Katzenstein D.A. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. AIDS Res Hum Retroviruses 2000, 16:645-653.
3. Hogg R.S., Yip B., Chan K.J., Wood E., Craib K.J., O'Shaughnessy M.V., et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001, 286:2568-2577.
4. Sabin C.A., Griffioen A., Yee T.T., Emery V.C., Herrero-Martinez E., Phillips A.N., et al. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. Lancet 2002, 360:1546-1551.
5. Harbol A.W., Liesveld J.L., Simpson-Haidaris P.J., Abboud C.N. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 1994, 8:241-251.
6. Ballem P.J., Belzberg A., Devine D.V., Lyster D., Spruston B., Chambers H., et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992, 327:1779-1784.
7. Mofenson L.M., Harris D.R., Moye J., Bethel J., Korelitz J., Read J.S., et al. Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings. Lancet 2003, 362:1625-1627.
8. Abrams D.I., Steinhart C., Frascino R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS 2000, 11:659-665.
9. Grossman H.A., Goon B., Bowers P., Leitz G. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2003, 34:368-378.
10. Saag M.S., Bowers P., Leitz G.J., Levine A.M. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. AIDS Res Hum Retroviruses 2004, 20:1037-1045.
11. Sullivan P.S., Hanson D.L., Chu S.Y., Jones J.L., Ward J.W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood 1998, 91:301-308.
12. Mocroft A., Kirk O., Barton S.E., Dietrich M., Proenca R., Colebunders R., et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 1999, 13:943-950.
13. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev 2002, 4:13-20.
14. Semba R.D., Shah N., Klein R.S., Mayer K.H., Schuman P., Vlahov D. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002, 34:260-266.
15. Mekonnen Y., Dukers N.H., Sanders E., Dorigo W., Wolday D., Schaap A., et al. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS 2003, 17:815-819.
16. Evans R.H., Scadden D.T. Haematological aspects of HIV infection. Baillieres Best Pract Res Clin Haematol 2000, 13:215-230.
17. Antelman G., Msamanga G.I., Spiegelman D., Urassa E.J., Narh R., Hunter D.J., et al. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. J Nutr 2000, 130:1950-1957.
18. Levine A.M., Karim R., Mack W., Gravink D.J., Anastos K., Young M., et al. Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Arch Intern Med 2006, 166:405-410.
19. Holzman R.S., Walsh C.M., Karpatkin S. Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nonthrombocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med 1987, 106:383-386.
20. Karpatkin S. HIV-1-related thrombocytopenia. Baillieres Clin Haematol 1990, 3:115-138.
21. Shah S., Smith C.J., Lampe F., Youle M., Johnson M.A., Phillips A.N., et al. Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with gender. HIV Med 2007, 8:38-45.
22. Curkendall S.M., Richardson J.T., Emons M.F., Fisher A.E., Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2007, 8:483-490.
23. Sullivan P.S., Hanson D.L., Chu S.Y., Jones J.L., Ciesielski C.A. Surveillance for thrombocytopenia in persons infected with HIV: results from the Multistate Adult and Adolescent Spectrum of Disease Project. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:374-379.
24. Moore R.D., Keruly J.C., Chaisson R.E. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:29-33.
25. Kowalska J.D., Mocroft A., Blaxhult A., Colebunders R., van Lunzen J., Podlekareva D., et al. Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection. AIDS Res Hum Retroviruses 2007, 23:1183-1188.
26. Harris R.J., Sterne J.A., Abgrall S., Dabis F., Reiss P., Saag M., et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 2008, 13:959-967.
27. Obirikorang C., Yeboah F.A. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009, 16:102.